Tags

Type your tag names separated by a space and hit enter

Six-and 12-month follow-up of an interdisciplinary fibromyalgia treatment programme: results of a randomised trial.

Abstract

OBJECTIVES

To assess the efficacy of a 6-week interdisciplinary treatment that combines coordinated psychological, medical, educational, and physiotherapeutic components (PSYMEPHY) over time compared to standard pharmacologic care.

METHODS

Randomised controlled trial with follow-up at 6 months for the PSYMEPHY and control groups and 12 months for the PSYMEPHY group. Participants were 153 outpatients with FM recruited from a hospital pain management unit. Patients randomly allocated to the control group (CG) received standard pharmacologic therapy. The experimental group (EG) received an interdisciplinary treatment (12 sessions). The main outcome was changes in quality of life, and secondary outcomes were pain, physical function, anxiety, depression, use of pain coping strategies, and satisfaction with treatment as measured by the Fibromyalgia Impact Questionnaire, the Hospital Anxiety and Depression Scale, the Coping with Chronic Pain Questionnaire, and a question regarding satisfaction with the treatment.

RESULTS

Six months after the intervention, significant improvements in quality of life (p=0.04), physical function (p=0.01), and pain (p=0.03) were seen in the PSYMEPHY group (n=54) compared with controls (n=56). Patients receiving the intervention reported greater satisfaction with treatment. Twelve months after the intervention, patients in the PSYMEPHY group (n=58) maintained statistically significant improvements in quality of life, physical functioning, pain, and symptoms of anxiety and depression, and were less likely to use maladaptive passive coping strategies compared to baseline.

CONCLUSIONS

An interdisciplinary treatment for FM was associated with improvements in quality of life, pain, physical function, anxiety and depression, and pain coping strategies up to 12 months after the intervention.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Research Unit, Hospital Galdakao-Usansolo, Bizkaia, Spain. josune.martincorral@osakidetza.net

    , , , , , ,

    Source

    MeSH

    Adaptation, Psychological
    Adult
    Ambulatory Care
    Anxiety
    Chi-Square Distribution
    Chronic Pain
    Combined Modality Therapy
    Cooperative Behavior
    Depression
    Female
    Fibromyalgia
    Humans
    Male
    Middle Aged
    Pain Clinics
    Pain Management
    Pain Measurement
    Patient Care Team
    Patient Satisfaction
    Prospective Studies
    Quality of Life
    Spain
    Surveys and Questionnaires
    Time Factors
    Treatment Outcome

    Pub Type(s)

    Journal Article
    Randomized Controlled Trial
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    23261008

    Citation

    Martín, Josune, et al. "Six-and 12-month Follow-up of an Interdisciplinary Fibromyalgia Treatment Programme: Results of a Randomised Trial." Clinical and Experimental Rheumatology, vol. 30, no. 6 Suppl 74, 2012, pp. 103-11.
    Martín J, Torre F, Padierna A, et al. Six-and 12-month follow-up of an interdisciplinary fibromyalgia treatment programme: results of a randomised trial. Clin Exp Rheumatol. 2012;30(6 Suppl 74):103-11.
    Martín, J., Torre, F., Padierna, A., Aguirre, U., González, N., García, S., ... Quintana, J. M. (2012). Six-and 12-month follow-up of an interdisciplinary fibromyalgia treatment programme: results of a randomised trial. Clinical and Experimental Rheumatology, 30(6 Suppl 74), pp. 103-11.
    Martín J, et al. Six-and 12-month Follow-up of an Interdisciplinary Fibromyalgia Treatment Programme: Results of a Randomised Trial. Clin Exp Rheumatol. 2012;30(6 Suppl 74):103-11. PubMed PMID: 23261008.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Six-and 12-month follow-up of an interdisciplinary fibromyalgia treatment programme: results of a randomised trial. AU - Martín,Josune, AU - Torre,Fernando, AU - Padierna,Angel, AU - Aguirre,Urko, AU - González,Nerea, AU - García,Susana, AU - Matellanes,Begoña, AU - Quintana,José M, Y1 - 2012/12/14/ PY - 2012/07/23/received PY - 2012/11/12/accepted PY - 2012/12/25/entrez PY - 2013/2/27/pubmed PY - 2013/3/15/medline SP - 103 EP - 11 JF - Clinical and experimental rheumatology JO - Clin. Exp. Rheumatol. VL - 30 IS - 6 Suppl 74 N2 - OBJECTIVES: To assess the efficacy of a 6-week interdisciplinary treatment that combines coordinated psychological, medical, educational, and physiotherapeutic components (PSYMEPHY) over time compared to standard pharmacologic care. METHODS: Randomised controlled trial with follow-up at 6 months for the PSYMEPHY and control groups and 12 months for the PSYMEPHY group. Participants were 153 outpatients with FM recruited from a hospital pain management unit. Patients randomly allocated to the control group (CG) received standard pharmacologic therapy. The experimental group (EG) received an interdisciplinary treatment (12 sessions). The main outcome was changes in quality of life, and secondary outcomes were pain, physical function, anxiety, depression, use of pain coping strategies, and satisfaction with treatment as measured by the Fibromyalgia Impact Questionnaire, the Hospital Anxiety and Depression Scale, the Coping with Chronic Pain Questionnaire, and a question regarding satisfaction with the treatment. RESULTS: Six months after the intervention, significant improvements in quality of life (p=0.04), physical function (p=0.01), and pain (p=0.03) were seen in the PSYMEPHY group (n=54) compared with controls (n=56). Patients receiving the intervention reported greater satisfaction with treatment. Twelve months after the intervention, patients in the PSYMEPHY group (n=58) maintained statistically significant improvements in quality of life, physical functioning, pain, and symptoms of anxiety and depression, and were less likely to use maladaptive passive coping strategies compared to baseline. CONCLUSIONS: An interdisciplinary treatment for FM was associated with improvements in quality of life, pain, physical function, anxiety and depression, and pain coping strategies up to 12 months after the intervention. SN - 0392-856X UR - https://www.unboundmedicine.com/medline/citation/23261008/full_citation L2 - http://www.clinexprheumatol.org/pubmed/find-pii.asp?pii=23261008 DB - PRIME DP - Unbound Medicine ER -